Future of Microcarriers and Recent Developments

The global microcarrier market was valued USD 1.83 Billion in 2021 and is expected to exhibit a CAGR of 9.32% over the forecast period from 2021 to 2030, as per a market study by Quince Market Insights.

Recent Developments in the Global Microcarrier Market
• January 2021 – The 500 L HyPerforma DynaDrive S.U.B. system from Thermo Fisher Scientific (U.S.) offers better performance and scalability for superior cell culture performance.
• November 2020 – Researchers from the Singapore-MIT Alliance for Science and Technology (SMART) created a dissolvable, gelatin-based microcarrier for large-scale cell production and expansion that gives improved yield and cost-effectiveness.
• October 2020 – Cytiva (U.S.), a global provider of medicines research and manufacturing technology and services, announced plans to establish an 80,000-square-foot production facility in Shrewsbury, Massachusetts, by the end of 2020. In addition, the corporation spent USD 500 million to expand its global manufacturing capacity.
• April 2020 – Danaher Corporation's (U.S.) SoloHill portfolio was acquired by Sartorius. Danaher's bio science division included SoloHill, which specialized in microcarrier technology. Sartorius has added to its microcarrier product line with this acquisition.

Key players:
Thermo Fisher Scientific (Waltham, Massachusetts), Corning Incorporated (Corning (city), New York), Merck (Kenilworth, New Jersey), Lonza Group (Basel), Getinge AB (Gothenburg), ChemoMetec (Scandinavia), Cesco Bioengineering (Trevose, Pennsylvania), Himedia Laboratories (Mumbai, India), Esco VacciXcell (Changi South, Singapore), Sartorius(Sartorius), Danaher Corporation(Washington, D.C), Becton(Franklin Lakes, NJ), Dickinson and Company (Franklin Lakes, New Jersey), and Eppendorf AG (Barkhausenweg 1, Hamburg)

Leave a Reply

Your email address will not be published.